首页> 外文期刊>Diabetes >Cardiorespiratory Fitness and Insulin Sensitivity in Overweight or Obese Subjects May Be Linked Through Intrahepatic Lipid Content
【24h】

Cardiorespiratory Fitness and Insulin Sensitivity in Overweight or Obese Subjects May Be Linked Through Intrahepatic Lipid Content

机译:超重或肥胖受试者的心脏呼吸适应性和胰岛素敏感性可能与肝内脂质含量有关

获取原文
获取原文并翻译 | 示例
       

摘要

Objective-Low cardiorespiratory fitness (CRF) predisposes one to cardiovascular disease and type 2 diabetes in part independently of body weight. Given the close relationship between intrahepatic lipid content (IHL) and insulin sensitivity, we hypothesized that the direct relationship between fitness and insulin sensitivity may be explained by IHL.rnRESEARCH DESIGN AND METHODS-We included 138 overweight to obese, otherwise healthy subjects (aged 43.6 ± 8.9 years, BMI 33.8 ± 4 kg/m~2). Body composition was estimated by bioimpedance analyses. Abdominal fat distribution, intramyocel-lular, and IHL were assessed by magnetic resonance spectros-copy and tomography. Incremental exercise testing was performed to estimate an individual's CRF. Insulin sensitivity was determined during an oral glucose tolerance testrnRESULTS-For all subjects, CRF was related to insulin sensitivity (r = 0.32, P < 0.05), IHL (r = -0.27, P < 0.05), and visceral (r = -0.25, P < 0.05) and total fat mass (r = -0.32, P < 0.05), but not to intramyocellular lipids (r = -0.08, NS). Insulin sensitivity correlated significantly with all fat depots, In multi-variate regression analyses, independent predictors of insulin sensitivity were IHL, visceral fat, and fitness (r~2 = -0.43, P < 0.01, r~2 = -0.34, and r~2 = 0.29, P < 0.05, respectively). However, the positive correlation between fitness and insulin sensitivity was abolished after adjustment for IHL (r = 0.16, NS), whereas it remained significant when adjusted for visceral or total body fat. Further, when subjects were grouped into high versus low IHL, insulin sensitivity was higher in those subjects with low IHL, irrespective of fitness levels.rnCONCLUSIONS-Our study suggests that the positive effect of increased CRF on insulin sensitivity in overweight to obese subjects may be mediated indirectly through IHL reduction.
机译:客观-低心肺适应(CRF)使一种人容易患心血管疾病和2型糖尿病,部分与体重无关。考虑到肝内脂质含量(IHL)与胰岛素敏感性之间的密切关系,我们假设IHL可能解释了适应性与胰岛素敏感性之间的直接关系。研究设计与方法-我们纳入了138例肥胖超重的健康受试者(43.6岁) ±8.9年,BMI 33.8±4 kg / m〜2)。通过生物阻抗分析估计身体组成。通过磁共振波谱和断层扫描评估腹部脂肪分布,子宫内膜和IHL。进行递增运动测试以估计个人的CRF。结果-在所有受试者中,CRF与胰岛素敏感性(r = 0.32,P <0.05),IHL(r = -0.27,P <0.05)和内脏(r = -0.25)有关,P <0.05)和总脂肪量(r = -0.32,P <0.05),而不是肌内脂质(r = -0.08,NS)。胰岛素敏感性与所有脂肪库均显着相关,在多变量回归分析中,胰岛素敏感性的独立预测因子为IHL,内脏脂肪和健康状况(r〜2 = -0.43,P <0.01,r〜2 = -0.34和r 〜2 = 0.29,P <0.05)。但是,调整IHL后,健康度和胰岛素敏感性之间的正相关关系被消除(r = 0.16,NS),而调整内脏脂肪或总体内脂肪后,它仍然很显着。此外,当将受试者分为高IHL与低IHL时,无论健康水平如何,低IHL的受试者胰岛素敏感性更高。结论-我们的研究表明,CRF升高对肥胖受试者超重对胰岛素敏感性的积极作用可能是通过减少国际人道法间接介导。

著录项

  • 来源
    《Diabetes》 |2010年第7期|P.1640-1647|共8页
  • 作者单位

    Franz Volhard Clinical Research Center at the Experimental and Clinical Research Center, Charity University Medical School and Max Delbriick Center for Molecular Medicine, Berlin, Germany;

    Institute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany;

    Franz Volhard Clinical Research Center at the Experimental and Clinical Research Center, Charity University Medical School and Max Delbriick Center for Molecular Medicine, Berlin, Germany;

    Franz Volhard Clinic, Charity University Medical School and Helios Klini-kum, Berlin, Germany;

    Franz Volhard Clinic, Charity University Medical School and Helios Klini-kum, Berlin, Germany;

    Franz Volhard Clinical Research Center at the Experimental and Clinical Research Center, Charity University Medical School and Max Delbriick Center for Molecular Medicine, Berlin, Germany;

    Franz Volhard Clinical Research Center at the Experimental and Clinical Research Center, Charity University Medical School and Max Delbriick Center for Molecular Medicine, Berlin, Germany;

    Franz Volhard Clinical Research Center at the Experimental and Clinical Research Center, Charity University Medical School and Max Delbriick Center for Molecular Medicine, Berlin, Germany;

    Franz Volhard Clinical Research Center at the Experimental and Clinical Research Center, Charity University Medical School and Max Delbriick Center for Molecular Medicine, Berlin, Germany;

    Department of Diagnostic and Interven-tional Radiology and Neuroradiology, University, Duisburg-Essen, Germany;

    Franz Volhard Clinical Research Center at the Experimental and Clinical Research Center, Charity University Medical School and Max Delbriick Center for Molecular Medicine, Berlin, Germany;

    Franz Volhard Clinical Research Center at the Experimental and Clinical Research Center, Charity University Medical School and Max Delbriick Center for Molecular Medicine, Berlin, Germany;

    Institute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:37

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号